Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A state-of-the-art review on the NRF2 in Hepatitis virus-associated liver cancer
Leila Kalantari, Zahra Rostami Ghotbabadi, Arsalan Gholipour, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 18

Showing 18 citing articles:

Increasing the sensitivity and accuracy of detecting exosomes as biomarkers for cancer monitoring using optical nanobiosensors
Saman Yasamineh, Naghmeh Nikben, Mareb Hamed Ahmed, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 12
Hepatitis C virus and hepatocellular carcinoma: carcinogenesis in the era of direct-acting antivirals
Felix Fiehn, Claudia Beisel, Marco Binder
Current Opinion in Virology (2024) Vol. 67, pp. 101423-101423
Open Access | Times Cited: 9
NRF2-mediated regulation of lipid pathways in viral infection
Khursheed Muzammil, Zahraa Sabah Ghnim, Ibrahim Saeed Gataa, et al.
Molecular Aspects of Medicine (2024) Vol. 97, pp. 101279-101279
Closed Access | Times Cited: 7
The role of lipids and lipids lowering drugs in human papillomavirus (HPV) and HPV-associated cancers
Ehsan Shabani, Aida Hasanzadi, Omer Qutaiba B. Allela, et al.
Infectious Agents and Cancer (2025) Vol. 20, Iss. 1
Open Access
The Malignant Transformation of Viral Hepatitis to Hepatocellular Carcinoma: Mechanisms and Interventions
Huimin Yuan, Ruochen Xu, Senlin Li, et al.
MedComm (2025) Vol. 6, Iss. 3
Open Access
Shrimp Virus Regulates ROS Dynamics via the Nrf2 Pathway to Facilitate Viral Replication
Honghui He, Kai Yuan, Jia Pan, et al.
Advanced Science (2025)
Open Access
Resveratrol mitigates oxidative stress and suppresses HBV replication via modulation of the SIRT1-Nrf2 pathway in liver cells
Gang Yang, Tao Li, Xiong Zhang, et al.
Future Virology (2025), pp. 1-10
Closed Access
Effect of Nrf2 Activators in Hepatitis B Virus-Infected Cells Under Oxidative Stress
Junsei Taira, Takuya Kubo, Hitoshi Nagano, et al.
Marine Drugs (2025) Vol. 23, Iss. 4, pp. 155-155
Open Access
Dual role of Nrf2 signaling in hepatocellular carcinoma: promoting development, immune evasion, and therapeutic challenges
Lin Gan, Weimin Wang, Jinxiu Jiang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
The role of cellular lipid metabolism and lipid-lowering drugs in periodontitis
Mohammad Kiarashi, Saman Yasamineh
International Immunopharmacology (2025) Vol. 152, pp. 114434-114434
Closed Access
Liver Cancer 2.0
Hiroaki Taniguchi
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17275-17275
Open Access | Times Cited: 9
Precision targeting in hepatocellular carcinoma: Exploring ligand-receptor mediated nanotherapy
Xiaqing Zhou, Yaping Li, Shuangsuo Dang
World Journal of Hepatology (2024) Vol. 16, Iss. 2, pp. 164-176
Open Access | Times Cited: 3
Enhanced SLC35B2/SAV1 sulfation axis promotes tumor growth by inhibiting Hippo signaling in HCC
Bo He, Zhao Huang, Siyuan Qin, et al.
Hepatology (2024)
Closed Access | Times Cited: 2
Liver cancer wars: plant-derived polyphenols strike back
Chengu Niu, Jing Zhang, Patrick Okolo
Medical Oncology (2024) Vol. 41, Iss. 5
Closed Access | Times Cited: 1
Biomarker potential of nuclear Nrf2 activation in the ABC subtype of diffuse large B‑cell lymphoma
Chin‐Mu Hsu, Shih‐Yu Kao, Chia‐Hung Yen, et al.
Oncology Letters (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 1
Association of Pro-Inflammatory Diet, Smoking, and Alcohol Consumption with Bladder Cancer: Evidence from Case–Control and NHANES Studies from 1999 to 2020
Chunying Teng, Weihong Lu, J.H. Che, et al.
Nutrients (2024) Vol. 16, Iss. 11, pp. 1793-1793
Open Access
Penfluridol suppresses MYC-driven ANLN expression and liver cancer progression by disrupting the KEAP1–NRF2 interaction
Minh Tuan Nguyen, Gi Jeong Lee, Bo Ram Kim, et al.
Pharmacological Research (2024) Vol. 210, pp. 107512-107512
Open Access
Oxidative Stress Induced by Antivirals: Implications for Adverse Outcomes During Pregnancy and in Newborns
Bárbara Costa, Maria João Gouveia, Nuno Vale
Antioxidants (2024) Vol. 13, Iss. 12, pp. 1518-1518
Open Access
Page 1

Scroll to top